Definition of First-Line Endocrine Therapy for Hormone Receptor-Positive Advanced Breast Cancer

被引：5
|
作者：
Reinert, Tomas [1 ]
Barrios, Carlos H. [2 ]
机构：
[1] Inst Canc Res, Sistema Saude Mae Deus, Porto Alegre, RS, Brazil
[2] Pontificia Univ Catolica Rio Grande do Sul, Sch Med, Porto Alegre, RS, Brazil
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 16期
关键词：
AROMATASE INHIBITORS; ANASTROZOLE; FULVESTRANT; COMBINATION;
D O I：
10.1200/JCO.2015.66.0803
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1959 / +
页数：3
相关论文
共 50 条
  • [1] Definition of First-Line Endocrine Therapy for Hormone Receptor-Positive Advanced Breast Cancer Reply
    Ellis, Matthew J.
    Robertson, John F. R.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (16) : 1960 - +
  • [2] A clinical calculator to predict disease outcomes in women with hormone receptor-positive advanced breast cancer treated with first-line endocrine therapy
    Mei-Yin C. Polley
    Maura N. Dickler
    Jason Sinnwell
    Kathleen Tenner
    Juan de la Haba
    Sibylle Loibl
    Matthew P. Goetz
    Jonas Bergh
    John Roberston
    Fergus Couch
    Matthew J. Ellis
    Miguel Martin
    [J]. Breast Cancer Research and Treatment, 2021, 189 : 15 - 23
  • [3] A clinical calculator to predict disease outcomes in women with hormone receptor-positive advanced breast cancer treated with first-line endocrine therapy
    Polley, Mei-Yin C.
    Dickler, Maura N.
    Sinnwell, Jason
    Tenner, Kathleen
    de la Haba, Juan
    Loibl, Sibylle
    Goetz, Matthew P.
    Bergh, Jonas
    Roberston, John
    Couch, Fergus
    Ellis, Matthew J.
    Martin, Miguel
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2021, 189 (01) : 15 - 23
  • [4] Advances in Endocrine Therapy for Hormone Receptor-Positive Advanced Breast Cancer
    Sharvina Ziyeh
    Lauren Wong
    Reva K. Basho
    [J]. Current Oncology Reports, 2023, 25 : 689 - 698
  • [5] Advances in Endocrine Therapy for Hormone Receptor-Positive Advanced Breast Cancer
    Ziyeh, Sharvina
    Wong, Lauren
    Basho, Reva K.
    [J]. CURRENT ONCOLOGY REPORTS, 2023, 25 (07) : 689 - 698
  • [6] Anastrozole is superior to tamoxifen as first-line therapy in hormone receptor-positive advanced breast carcinoma
    Gluck, S
    [J]. CANCER, 2002, 95 (11) : 2442 - 2443
  • [7] Potential role for mammalian target of rapamycin inhibitors as first-line therapy in hormone receptor-positive advanced breast cancer
    Beck, J. Thaddeus
    [J]. ONCOTARGETS AND THERAPY, 2015, 8 : 3629 - 3638
  • [8] First-line ribociclib plus endocrine therapy in hormone receptor-positive, HER2-negative advanced breast cancer: A pooled efficacy analysis
    Tripathy, D.
    Hortobagyi, G.
    Chan, A.
    Im, S-A
    Chia, S.
    Yardley, D.
    Esteva, F. J.
    Hurvitz, S.
    Kong, O.
    Bao, W.
    Lorenc, K. Rodriguez
    Diaz-Padilla, I.
    Slamon, D. J.
    [J]. CANCER RESEARCH, 2019, 79 (04)
  • [9] Endocrine Therapy in Premenopausal Hormone Receptor-Positive Breast Cancer
    Tevaarwerk, Amye J.
    Wisinski, Kari B.
    O'Regan, Ruth M.
    [J]. JOURNAL OF ONCOLOGY PRACTICE, 2016, 12 (11) : 1148 - +
  • [10] Enhancing Endocrine Therapy for Hormone Receptor-Positive Advanced Breast Cancer: Cotargeting Signaling Pathways
    Johnston, Stephen R. D.
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2015, 107 (10)
12345